Cellular Adaptations
On this page
Direct answer
Hypertrophy, hyperplasia, atrophy and metaplasia are the four adaptive responses through which cells reach a new steady state between normal and injury — size increase in terminally differentiated cells, number increase where division is permitted, shrinkage when workload or nutrition falls, and reversible phenotype substitution when chronic irritation makes a hardier cell type fitter. Each adaptation has a molecular switch: trophic signals drive protein synthesis or gene expression, and their withdrawal drives ubiquitin-proteasome degradation and autophagy. Adaptations are reversible, but two of them create the terrain for cancer — metaplasia of bronchial epithelium in smokers and dysplasia on top of it, and intestinal metaplasia of the oesophagus (Barrett oesophagus) setting up adenocarcinoma.
What you must remember
- Hypertrophy: increase in cell size; the only option in cardiac and skeletal myocytes and neurons; physiological (uterine smooth muscle in pregnancy, athlete's heart) or pathological (hypertension, aortic stenosis). Mechanistically driven by mechanical sensors, growth factors and agonists activating gene transcription and protein synthesis.
- Hyperplasia: increase in cell number; hormone-driven (endometrium, prostate in elderly men), compensatory (hepatic lobectomy, contralateral kidney), or pathological (endometrial hyperplasia on unopposed oestrogen). Pregnancy uterus combines hypertrophy and hyperplasia; heart manages hypertrophy alone.
- Atrophy: shrinkage from disuse, denervation, ischaemia, prolonged pressure, malnutrition or hormone loss; mediated by ubiquitin-proteasome degradation with autophagy leaving lipofuscin pigment — the brown atrophy heart of the elderly.
- Metaplasia anchors: columnar-to-squamous in smoker bronchus, cervix, and gallbladder chronic cholecystitis; squamous-to-columnar in Barrett oesophagus (intestinal type, CDX2-positive) and gastric intestinalisation in chronic gastritis; osseous metaplasia in myositis ossificans.
- Dysplasia: disordered maturation with nuclear atypia confined to the epithelium; graded mild to severe or low/high grade; reversible if the irritant goes, but carcinoma in situ means full-thickness change with an intact basement membrane.
- Indian anchor: cervical squamous metaplasia at the transformation zone is where HPV integrates — the reason VIA and Pap screening under the national programme target the cervix even though cervical cancer incidence in India has been slowly declining.
- Aplasia versus hypoplasia versus atrophy: aplasia means the organ never formed, hypoplasia means it formed small, atrophy means it formed normally then shrank — a favourite one-liner viva distinction.
Why each adaptation exists
Think of adaptation as negotiation between demand and supply. A cardiac myocyte cannot divide — its cell-cycle exit is irreversible — so when afterload rises it can only enlarge, laying down sarcomeres in parallel until oxygen supply fails and myocyte dropout, interstitial fibrosis and eventually failure follow. Hepatocytes retain full replicative capacity, so losing 70 per cent of the liver triggers hyperplasia restoring mass within weeks, which is what makes living-donor transplantation possible. Denervated muscle shrinks because trophic neural signals, not just contraction, maintain protein synthesis — the same reason a limb in a cast loses bulk despite normal blood supply. Metaplasia is stem-cell reprogramming: chronic irritation selects for a tougher phenotype, so reserve cells in the bronchus differentiate squamous under tobacco smoke. The trade-off is that squamous epithelium lacks cilia and mucus, losing mucociliary clearance, and the persisting insult drives the new epithelium through dysplasia toward squamous carcinoma. In Barrett oesophagus the reprogramming goes the other way — acid bile reflux selects for intestinal-type columnar cells that resist injury but carry malignant potential; progression is monitored by sequential biopsy for dysplasia.
Where candidates slip
The recurring error is calling every increase "hyperplasia" — the pregnant uterus manages both, but the heart, physiological or pathological, manages hypertrophy alone because adult myocytes have exited the cell cycle. The second slip is metaplasia versus dysplasia: metaplasia is a uniform, orderly swap of adult cell type; dysplasia is disorderly maturation with atypia, and only dysplasia sits on the direct road to cancer. Third, atrophy is often confused with hypoplasia in image questions of a small kidney — a shrunken kidney with scars and a thinned cortex acquired the lesion, it did not develop small. Finally, remember that compensatory hyperplasia of the residual kidney after nephrectomy is physiological adaptation with a pathological trigger — a phrasing examiners enjoy testing.
Frequently asked questions
Which adaptation is available to cardiac myocytes and why?
Hypertrophy alone, because adult cardiac myocytes are terminally differentiated and have exited the cell cycle, so increased workload can only increase cell size, not number.
What is the mechanism of atrophy at the molecular level?
Ubiquitin-proteasome-mediated protein degradation plus autophagy of organelles, triggered by loss of trophic signals; residual indigestible lipid forms lipofuscin.
Why does Barrett oesophagus predispose to adenocarcinoma?
Chronic acid-bile reflux causes intestinal metaplasia, and the abnormal columnar epithelium can progress through low- and high-grade dysplasia to adenocarcinoma.
How do metaplasia and dysplasia differ fundamentally?
Metaplasia is reversible substitution of one mature cell type by another of the same lineage; dysplasia is disordered growth with cytological atypia confined by the basement membrane.
Which metaplasia occurs in chronic cholecystitis?
Squamous metaplasia of gallbladder columnar epithelium under chronic stone irritation, occasionally progressing to squamous carcinoma of the gallbladder.